Botanix Pharmaceuticals Stock Forecast

ASX-BOT's stock price has decreased by -92.54% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 analysts polled by S&P Global, Botanix Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $0.49. The average 1-year stock price forecast is 2,127.27% higher than the current stock price, while the lowest is $0.14 (+536.36%) and the highest is $1.00 (+4,445.45%).

Price Target: $0.49 (+2,127.27%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$0.14	$0.49	$0.33	$1.00
Change	+536.36%	+2127.3%	+1400.0%	+4445.5%

* Price targets were last updated on May 4, 2026.

Analyst Ratings

The average analyst rating for Botanix Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	0	1	1
Hold	0	0	0	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Madeleine Williams Canaccord Genuity	Canaccord Genuity	Buy Maintains $0.14	Buy	Maintains	$0.14	+536.36%	May 4, 2026
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Reiterates $1.00	Buy	Reiterates	$1.00	+4,445.45%	Apr 29, 2026

Financial Forecast

Revenue This Year

35.80M

from 5.79M

518.39%

from 5.79M

Revenue Next Year

73.93M

from 35.80M

106.52%

from 35.80M

EPS This Year

-0.02

from -0.05

EPS Next Year

-0.01

from -0.02

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	6.89M	2.75M	3.77M	2.07M	5.79M	35.80M
Revenue Growth	-9.07%	-60.00%	36.94%	-45.14%	179.74%	518.39%
Gross Profit	315.80K	-7.54M	-1.96M	-1.58M	2.02M	27.03M
Gross Margin	4.59%	-273.62%	-51.83%	-76.48%	34.85%	75.50%
Operating Income	-3.38M	-13.19M	-9.13M	-13.99M	-82.91M	-57.93M
Net Income	-3.33M	-13.17M	-9.15M	-13.87M	-86.40M	-64.00M
EPS	-	-	-	-	-0.05	-0.02
Free Cash Flow	-1.78M	-9.00M	-15.57M	-20.30M	-38.58M	-58.30M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue	2026	2027	2028
High	38.7M
Avg	35.8M
Low	33.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	568.5%
Avg	518.4%
Low	480.4%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.02
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-